Owlet, Inc.
NYSE:OWLTMedical - Devices
+$0.46 today
- Market cap
- $107.24M
- Beta
- 1.86
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$12.67
Volume 0.64M
Average 0.24M
OWLT Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Owlet, Inc.NYSE: OWLT
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns negative
Q1 FY2026 net income was -$3.34M, compared with $3.03M a year earlier. Trailing-twelve-month net income was -$46.04M. Over 3 fiscal years it compounded at -21.4% a year.
Context
- Net income amounted to 36.4% of revenue in FY2025, up 20.3 pp from a year earlier.
- Net income grew in size in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 3 analysts of -$6.6M (-82.8%) for the fiscal year ending Dec 2026, a slowdown from the +206.8% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$3.34M-63.7% QoQ
- Last fiscal yearDec 2025
- -$38.46M+206.8% YoY
- LTMMar 2026
- -$46.04M+260.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -210.3% | -92.9% | +117.3 pp |
| 1 year | +206.8% | -82.8% | -289.7 pp |
| 3-year CAGR | -21.4% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (38.46M) USD
- Year-over-year change
- -206.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (38.46M) | -206.8% |
| FY2024 | 2024-12-31 | (12.54M) | +61.9% |
| FY2023 | 2023-12-31 | (32.9M) | +58.5% |
| FY2022 | 2022-12-31 | (79.34M) | -10.6% |
| FY2021 | 2021-12-31 | (71.7M) | — |
Net Income vs competitors
How OWLT compares with its peers on the latest reported figures
- OWLT's LTM Mar 2026 net income of $46.04M is the 5th largest of the 10 companies compared; the peer median is $44.76M.
- Its year-over-year change of +260.1% is the 2nd highest of 10, against a peer median of +7.6%.
- Net income amounts to 43.0% of revenue for OWLT, versus a peer median of 145.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $26.68B | +43056.2% | +1.1% | 519699.0% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $88.03M | +7.6% | +45.5% | 4756.0% |
| LTM Mar 2026 | $84.53M | +68.1% | +22.9% | — | |
| LTM Mar 2026 | $50.14M | +11.8% | -8.1% | 145.8% | |
| LTM Mar 2026 | $46.04M | +260.1% | -21.4% | 43.0% | |
| LTM Mar 2026 | $44.76M | -8.4% | +5.8% | 8526.1% | |
ELTXElicio Therapeutics, Inc. | LTM Mar 2026 | $40.19M | -21.6% | +11.9% | — |
| LTM Mar 2026 | $39.12M | -6.4% | +23.7% | 121.2% | |
| LTM Mar 2026 | $11.98M | +121.2% | +19.8% | 20.8% | |
| LTM Mar 2026 | $11.06M | -80.5% | -9.9% | 9.5% | |
| Peer median (excluding OWLT) | $44.76M | +7.6% | +11.9% | 145.8% | |
Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (71.7M) | (79.34M) | (32.9M) | (12.54M) | (38.46M) |
| Depreciation & Amortization | 1.13M | 2.67M | 2.21M | 1.38M | 590K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 4.26M | 12.86M | 9.93M | 8.63M | 9.35M |
| Change in Working Capital | 9.45M | (15.2M) | (4.82M) | (2.52M) | (10.71M) |
| Accounts Receivables | (144K) | (8.5M) | 965K | 2.03M | (10.97M) |
| Inventory | (11.65M) | (1.18M) | 12.12M | (4.14M) | (4.93M) |
| Accounts Payables | 32.12M | (10.72M) | (19.5M) | 1.32M | 5.43M |
| Other Working Capital | (10.87M) | 5.2M | 1.6M | (1.74M) | (236K) |
| Other Non-Cash Items | 16.3M | (2.37M) | 2.05M | (6.16M) | 28.43M |
| Operating Cash Flow | (40.56M) | (81.38M) | (23.53M) | (11.21M) | (10.8M) |
| Capital Expenditures | (2.02M) | (1.57M) | (59K) | (761K) | (273K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1.05M) | (929K) | (43K) | (726K) | 0 |
| Investing Cash Flow | (2.02M) | (1.57M) | (59K) | (761K) | (943K) |
| Debt Repayment | (3.49M) | (1.5M) | 156K | (816K) | 55K |
| Common Stock Issued | 0 | 0 | 0 | 10M | 34.69M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 124.11M | 618K | 269K | (2M) | (2.64M) |
| Financing Cash Flow | 120.62M | (878K) | 28.91M | 16.04M | 32.1M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 78.05M | (83.82M) | 5.33M | 4.07M | 20.38M |
| Free Cash Flow | (42.58M) | (82.95M) | (23.59M) | (11.97M) | (11.07M) |
Owlet, Inc.
NYSE:OWLT
Intrinsic Alpha fair value
Locked
Current Price
$3.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.